UBS raised the firm’s price target on Couchbase (BASE) to $20 from $18 and keeps a Neutral rating on the shares. Couchbase reported “solid” Q1 annual recurring revenue, but the revenue growth gap is widening, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BASE:
- Couchbase price target raised to $19 from $18 at Morgan Stanley
- Couchbase price target raised to $22 from $20 at Rosenblatt
- Couchbase price target raised to $20 from $16 at Piper Sandler
- Couchbase: Strong ARR Growth Amid Revenue Recognition Challenges Justifies Hold Rating
- Couchbase’s Strong ARR Growth and Strategic Investments Drive Buy Rating Despite Customer Churn Concerns